Adipocytes impact on gastric cancer progression: Prognostic insights and molecular features

Table 1 The training group included clinical and pathological features of gastric cancer patients, n = 428, n (%)

Clinical characteristics	Adipose infiltration			P value
	Low, n = 386	High, n = 42	Overall, n = 428
Age in yr				0.002
> 60	221 (57.30)	13 (31.00)	234 (54.70)
≤ 60	165 (42.70)	29 (69.00)	194 (45.30)
Sex				0.474
Male	265 (68.70)	26 (61.90)	291 (68.00)
Female	121 (31.30)	16 (38.10)	137 (32.00)
Perineural invasion				0.107
No	319 (82.60)	35 (83.30)	354 (82.70)
Yes	67 (17.40)	7 (16.70)	74 (17.30)
Vascular invasion				0.519
No	205 (53.10)	20 (47.60)	225 (52.60)
Yes	181 (46.90)	22 (52.40)	203 (47.40)
M stage				1.000
M0	371 (96.10)	41 (97.60)	412 (96.30)
M1	15 (3.90)	1 (2.40)	16 (3.70)
T stage				0.812
T1	11 (2.80)	0 (0.00)	11 (2.60)
T2	35 (9.10)	3 (7.10)	38 (8.90)
T3	83 (21.50)	8 (19.00)	91 (21.30)
T4	257 (66.60)	31 (73.80)	288 (67.30)
N stage				0.318
N0	71 (18.40)	8 (19.00)	79 (18.50)
N1	171 (44.30)	14 (33.30)	185 (43.20)
N2	114 (29.50)	18 (42.90)	132 (30.80)
N3	30 (7.80)	2 (4.80)	32 (7.50)